Cardiovascular status and events in patients with prostate cancer treated with a luteinising hormone-releasing hormone agonist or degarelix: A comparison of USA/Canada vs Europe

KEANE -_Poster1_Page_3

pdfDOWNLOAD FULL POSTER

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe